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Background: Cryoballoon isolation is considered a safe and effective treatment for atrial fibrilla-
tion (AF). However, recurrence of AF after first cryoballoon ablation occurs in ~30% of patients.
Pre-procedurally identifying patients at risk of AF recurrence could be beneficial.
Hypothesis: Our aim was to determine how pulmonary vein (PV) anatomy influences the recur-
rence of AF using the second-generation cryoballoon in patients with paroxysmal AF.
Methods: We included 88 consecutive patients with paroxysmal AF undergoing PVI procedure
with a second-generation 28-mm cryoballoon. All patients were evaluated at 3, 6 and
12 months using a 12-lead ECG and 24-hour Holter monitoring. PV anatomy was assessed by
creating three-dimensional models using computed tomography (CT) segmentations of the left
atrium.
Results: Fifty-one patients (61%) had left PVs with a shared carina, 35 patients (42%) had a
shared right carina. Nine patients (11%) were classified having a right middle PV. In total
17 (20.2%) of patients had a left common PV. At 12 months, 14 patients (17%) had experienced
AF recurrence. Neither PV ovality, variant anatomy, the presence of shared carina nor a com-
mon left PV was a predictor for AF recurrence.
Conclusions: No specific characteristics of PV dimensions nor morphology were associated with
AF recurrence after cryoballoon ablation in patients with paroxysmal AF.
KEYWORDS
anatomy, atrial fibrillation, computed tomography, cryoballoon ablation, outcome, pulmonary
veins
1 | INTRODUCTION
Atrial fibrillation (AF) is the most encountered arrhythmia in clinical
practice. In 2010, it was estimated that 33.6 million people suffer from
AF worldwide.1 Recent guidelines state that pulmonary vein isolation
(PVI) is considered first choice treatment.2 PVI using cryoballoon is a
common used ablation strategy, however, a significant proportion of
patient experience AF recurrences.3,4
Ablation outcome may be affected by clinical factors, such as type
of AF, left atrial (LA) size, comorbidities or operator experience.5,6
Besides these clinical characteristics, it has been suggested that PV
morphology may also affect outcome. PV anatomy is very heteroge-
neous and optimal circumferential contact between the cryoballoon
and PV/atrial myocardium is important for long-term freedom from
AF.7 Previous studies on the relationship between PV ovality and
cryoballoon ablation showed that a larger ovality index of the left
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inferior pulmonary vein (LIPV) has been found to predict AF recur-
rence in a group of paroxysmal and persistent AF patients.8,9 However
in previous studies both the first- and second-generation balloon with
different balloon sizes (23- and 28-mm) were used9 and a heteroge-
neous group of patients (both paroxysmal and/or persistent AF) were
included.8
The aim of the present study was to assess PV morphology and
variants including carina width, shared carina or PV ovality index and
whether this is of influence on AF recurrence after PVI with the sec-
ond generation 28 mm cryoballoon in a homogenous population of
patients with paroxysmal AF.
2 | METHODS
2.1 | Patients
Eighty-eight consecutive patients with drug-refractory paroxysmal AF
underwent second-generation cryoballoon ablation between February
2014 and February 2015 in the University Medical Center Groningen.
To ensure a homogenous group of patients, we included only patients
with paroxysmal AF who underwent second-generation cryoballoon
ablation therapy in this study. Of these patients, 84 had computed
tomography (CT) scans prior to the ablation procedure that could be
analyzed for PV dimensions and morphology and were included in this
analysis. All data were retrospectively collected from the patients'
medical files. All patients consented to the ablation procedure, all data
is anonymously gathered retrospectively and no additional studies
were performed, therefore, no ethical approval was obtained.
2.2 | CT image acquisition and analysis
Cardiac CT scanning was performed with a first generation dual-
source CT system (SOMATOM Definition, Siemens Healthcare, For-
chheim, Germany). Scan acquisitions were made with the patient at
inspiratory breath hold. A topogram was made to determine the scan
range, from a couple of centimeters above the carina to just below
the heart, to include all PVs entering the left atrium. CT scan protocols
details include: prospective ECG triggering, sequential mode with col-
limation 2 × 64 × 0.6 mm using a flying z-spot, tube voltage 100, 120,
or 140 kV (depending on patient size), gantry rotation time 330 ms,
reference tube current 220/200/196 mAs/rotation, respectively, elec-
trocardiography (ECG_-gated tube current modulation. The contrast
agent injected was iomeprol 350 or 400 mg/100 mL (Iomeron 350 or
400, Bracco Imaging S.p.A., Milan, Italy). The contrast bolus depended
on patient size and length of the scan, and was followed by a saline
flush. Contrast-enhanced cardiac CT scanning was performed at 70%
of the cardiac cycle. Computed tomography angiography (CTA) data
were reconstructed with as 1.2 mm consecutive slices in the axial
plane, using a smooth kernel (B30f). The cardiac radiologist performed
reporting in clinical setting, and reported on the lung vein anatomy,
left atrium and thrombus in left atrial appendage on the cardiac CT, as
well as side findings. For further analysis, CT scans were uploaded to
Syngo X Workplace VB21C (Siemens AG, Wittelsbacherplatz, Munich,
Germany) and segmented to obtain the LA. Subsequently, the scans
were transferred to CartoMerge (Biosense Webster, Diamond Bar,
California) for segmentation and analysis in the three-dimensional
field. The vein ostia were identified as the visual anatomical entry
point of the PVs in the atrial wall, which was the point with the high-
est inflection.10 Ostium of all PVs was identified and thereafter
assessment of carina width, vein diameter, and morphology. The
patient population was divided into two groups and analyzed by four
independent researchers, two for each group. Thus, each CT was ana-
lyzed twice by two independent researchers who were blinded to the
outcome of the clinical procedure. The order of CT scans was shuffled,
to account for a learning curve. The average of these measurements
was calculated and used in the analysis. In case of disagreement about
morphology, the case was discussed among the researchers until a
consensus was reached.
The carina was defined as the segment connecting ipsilateral adja-
cent PVs and was measured using the shortest possible line through
two points at the highest inflection of this portion (carina width). A
shared carina was defined as a carina width of <5 mm. The ostium
was assessed using multiplanar reformatting, measuring the largest
(Dmax), and smallest (Dmin) diameter of each PV entering the LA. The
ovality index was then calculated using the formula Dmax/Dmin.
Veins were classified as round (ovality index <1.2), oval (1.2-1.4) or flat
(>1.4).11,12 Left common pulmonary vein (PV) was defined as the pres-
ence of bifurcated PVs entering the left atrial contour together and a
distance between the virtual border of the left atrium and the bifurca-
tion of both PVs ≥5 mm.13
2.3 | Cryoballoon ablation procedure
The ablation procedure was performed under conscious sedation. LA
access was achieved with a single transseptal puncture. The target
ACT level was >300. The second-generation 28-mm cryoballoon
(Artic Front Advance, Cryocath) was used for ablation. At least two
cryothermal applications (lasting 240 seconds) were delivered to iso-
late each vein. During cryothermal ablation of the right PVs, diaphrag-
matic stimulation, using a quadripolar catheter placed in the superior
caval vein, was performed to avoid phrenic nerve injury. Electrical iso-
lation of the PVs was evaluated using the circular Achieve mapping
catheter (entrance block). In case of presence of remaining PV poten-
tials pacing within the PVs was performed with 10 mA to check for
exit block.
2.4 | Post-ablation management and follow-up
Three outpatient clinic visits were scheduled to follow the patients at
3, 6, and 12 months after the cryoballoon procedure, each preceded
by a 12-lead ECG and 24-hour Holter monitoring. During these visits,
medical history was obtained and physical examination was per-
formed. Patients presenting with AF symptoms were given an event
recorder to document possible recurrences. In addition, information
about AF, atrial flutter, or atrial tachycardia recurrence documented
by the general practitioner, during emergency room visits or during
hospital admissions was also collected. Antiarrhythmic medication
was continued during the first 3 months after the procedure, and then
discontinued in patients without symptoms of AF.
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2.5 | Covariate definitions
Time since first AF diagnosis was defined as the time from first docu-
mented AF episode till ablation date. Coronary artery disease was
defined as history of myocardial infarction, percutaneous coronary
intervention, or coronary artery bypass grafting. Hypertension was
defined as systolic blood pressure >140 mm Hg and diastolic blood
pressure >90 mm Hg or by use of antihypertensive medication. Body
mass index (BMI) was calculated as the ratio of weight (in kilograms)
to height (in meters) squared (kg/m2). Diabetes was defined as a fast-
ing plasma glucose ≥7.0 mmol/L, a non-fasting plasma glucose
≥11.1 mmol/L, or use of anti-diabetic drugs. AF was considered par-
oxysmal if all past AF episodes ended within a week of onset (self-
terminating or by cardioversion). CHA2DS2-VASc was defined
according to the European Society of Cardiology guidelines.
2.6 | Endpoints
The primary endpoint was the first recurrence of AF, atrial flutter, or
atrial tachycardia documented by ECG, Holter monitoring (episode
lasting for more than 30 seconds) or by an event recorder, or repeat
ablation during a follow-up of 12 months, excluding recurrences
occurring in the first 90 days (blanking period).
2.7 | Statistical analysis
Normally distributed continuous variables were given as mean ± SD,
skewed data as median with interquartile range and categorical data
as numbers with percentages. Normal distribution of data was
checked using Shapiro-Wilk W test for normal data. The χ2 was used
to compare nominal variables. Intraclass coefficient (ICC) estimates
between raters were calculated based on a mean-rating (k = 2), consis-
tency agreement, two-way mixed effects model. The first occurrence
of the primary outcome was assessed by Kaplan-Meier curves. Uni-
variate screening using Cox regression analysis was done to identify
predictors of AF recurrence. A univariate P < 0.2 was required for
entrance in a multivariate model. All tests of significance were two-
sided, with P-values of <0.05 assumed to indicate significance. Data
were analyzed with Stata version 13.0 (StataCorp, College Station,
Texas).
3 | RESULTS
3.1 | Patient population
In total, 84 patients with paroxysmal AF were included for the present
analysis. In our study population, 49 patients (58%) were male and
median age at inclusion was 59 ± 10 years. AF duration was 2.9
(1.2-6.6) years. A total of 47 patients (56%) had hypertension,
11 (13%) had diabetes mellitus, and 10 (12%) had coronary artery dis-
ease. Table 1 shows detailed patient characteristics. Total procedure
time of the cryoballon ablation was 118.9 ± 37.3 minutes. The total
number of cryo applications was 9.6 ± 2.7. Electrical isolation of the
PVs was achieved in 90.5% of patients. In total, 6 complications
occurred (data not shown): 2 (2.4%) phrenic nerve palsy (at discharge),
2 (2.4%) femoral pseudoaneurysm, 1 (1.2%) arterio-venous fistula, and
1.2% dissection of iliac vein.
3.2 | PV diameters
Measures of interobserver reproducibility revealed that all ICC esti-
mates were significant (data not shown), except for three variables. In
these instances, not enough (n = 3) measurements were made to pro-
duce reproducible results. Figure 1 shows examples of PV anatomy. In
total, 17 (20.2%) of patients had a left common PV (Figure 1A). Fifty-
one patients (61%) had a shared carina left, 35 patients (42%) had a
shared carina right (Figure 1B). Nine patients (11%) were classified
having a right middle PV (RMPV) (Figure 1D). Table 2 displays all mean
PV measurements including calculated ovality. Maximal diameters of
LSPV, LIPV, RSPV, and RIPV were respectively 19.5 (17.1-20.8), 17.4
(16.0-18.9), 20.5 (18.3-23.5), and 18.0 (15.8-20.6) mm.
3.3 | AF recurrence
At 12 months, 14 patients (17%) had experienced AF recurrence.
When compared to patients without recurrence, there was no
observed difference in ovality index in patients with AF recurrence







(n = 14) P-value
Age, mean ± SD 59 ± 10 58 ± 10 61 ± 9 0.32
Male sex, no. (%) 49 (58%) 41 (59%) 8 (57%) 0.92
Body mass index,
mean ± SD
28 ± 5 28 ± 5 29 ± 6 0.65




2.8 (1.2-6.9) 3.2 (0.8-5.0) 0.70
Hypertension,
no. (%)
47 (56%) 41 (59%) 6 (43%) 0.28
Diabetes mellitus,
no. (%)
11 (13%) 8 (11%) 3 (21%) 0.31
Coronary artery
disease, no. (%)
10 (12%) 10 (14%) 0 (0%) 0.13
CHA2DS2VASc
score 0 or 1, no.
(%)








54 (64%) 46 (66%) 8 (57%) 0.54
Use of flecainide or
propafenone,
no. (%)




20 (24%) 19 (27%) 1 (7%) 0.11
Use of amiodarone,
no. (%)




57 ± 2 57 ± 2 56 ± 3 0.10
Left atrial volume,
mean ± SD
31 ± 7 31 ± 8 29 ± 7 0.29
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(Table 3). Also, no significant interaction between a shared carina left
or right, or left common PV and AF recurrence at 12 months (Table 2)
was observed. No significant difference in AF recurrence was
observed between presence and absence of RMPV (17% vs 11%,
respectively, P = 0.64).
3.4 | Cox proportional hazard analysis
Univariate Cox regression (data not shown) showed that BMI
(HR = 0.91, 95% confidence interval [CI] = 0.79-1.05), usage of sota-
lol >160 mg/day (HR= 0.24, 95% CI = 0.03-1.80), LVEF (HR = 0.86,
95% CI = 0.70-1.05) and LAVI (HR = 0.94, 95% CI = 0.86-1.01) were
considered for entrance in our multivariable model. After multivariate
analysis none were significant. Table 4 shows the Cox regression for
the vein diameters, ovality index, shared carina, or morphological
characteristics of which none were considered a significant predictor
of AF recurrence.
4 | DISCUSSION
In the present study, we explored whether specific characteristics of
PV dimension or anatomy could predict outcome of cryoballoon abla-
tion in patients with paroxysmal AF. Neither PV ovality, the presence
of anatomical variants (right middle PVs, common ostia), shared carina
nor carina width influenced AF recurrence rate at 12 months.
As PVI outcome is difficult to predict because of many confounding
factors, we limited our analysis to a homogenous patient population
and reproducible ablation procedure, that is, paroxysmal AF patients
treated with a 28-mm second-generation cryoballoon. Other studies
evaluating the predictive value of PV dimensions and morphology on
ablation outcome used both the first- and second-generation bal-
loons, different sizes balloon (23- and 28-mm) and a heterogeneous
group of patients (both paroxysmal and/or persistent AF). In concor-
dance with previous studies, we found that 11% of patients had a
right middle PV.8,14 There was no association between the presence
of a right middle PV and AF recurrence. This has also been reported
in a comparable study (The Sustained Treatment of Paroxysmal Atrial
Fibrillation (STOP AF) trial.15 In this trial, early or late recurrence was
not associated with non-standard anatomy following cryoballoon
PVI.15 Another theory is that early branching of the RLPV predicts
AF recurrence.16 Several other studies have assessed PV morphol-
ogy and success of cryoballoon ablation.9,11,13 Principle findings
were that left-side PV ovality is more often observed than right-
sided ovality and that left-sided ovality is associated with more diffi-
cult isolation of the vein and more AF recurrence. We observed no
FIGURE 1 Examples of pulmonary vein anatomy. A, Left common pulmonary vein, B, shared carina, C, non shared carina, and D, right middle
pulmonary vein








20.8 (18.3-22.5) 20.8 (18.5-23.0) 0.83
LIPV max outer diameter,
median (IQR)




23.4 (20.5-25.9) 22.4 (20.5-26.1) 0.74
RIPV max outer diameter,
median (IQR)
20.2 (17.3-22.2) 19.1 (18.6-21.0) 0.49
Abbreviations: IQR, interquartile range; LIPV, left inferior pulmonary vein;
LSPV, left superior pulmonary vein; PV, pulmonary vein; RIPV, right infe-
rior pulmonary vein; RSPV, right superior pulmonary vein.
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difference for any PV diameter or ovality index. The difference
between our study and previous studies was a more heterogeneous
patient population including persistent and paroxysmal AF patients
or usage of a first-generation cryoballoon. The presently used
second-generation balloon has double the amount of cooling ports
and the balloon has a more evenly spread cooling zone. We hypothe-
sized that ablation with the first-generation cryoballoon in oval-
shaped PVs not all the tissue is affected by the cryoapplication. This
potentially may lead to higher recurrence rates. The more powerful
second-generation cryoballoon used in this study could explain why
PV ovality does not influence cryoballoon ablation success rate any-
more. This was also demonstrated in a recent study in patients with
a left common PV.17 In the present study, using a second-generation
cryoballoon, these patients had (compared with a control population)
similar high acute success rates and comparable durable results.17
AF triggers often originate from the right and left PV carina.18
Through histological and electrophysiological studies, the importance
of the carina in PVI was demonstrated.19–21 Crossing myocardial
strands and bridges at the interpulmonary isthmus may be the ana-
tomical substrate for electrical connection between superior and infe-
rior PVs.20 However, no studies investigated the role of the carina
width for predicting cryoballoon ablation success. Cryoapplications at
ipsilateral PVs result in multiple (at least 4 if 2 application are given
per vein) applications at the carina. In patients with small width carina
there is overlap of the cryoapplications. This may have impact on
durability of cryolesions and also on recurrence rate. We, however,
found no difference in carina width in patients with or without AF
recurrence.
4.1 | Limitations
Our study is limited by the limitations inherent to the retrospective
study design. Recurrences of AF were monitored by standard out-
patient clinic ECG and Holter monitoring, asymptomatic episodes of
AF will therefore been missed. Also, all PV diameters have been mea-
sured using a manual caliper function. A (semi-)automated caliper
function would produce more reliable and consistent results. The most
reliable results would have been produced through an algorithm that
calculates the exact location where the balloon touches the ostium,
based on the pre-procedural CT. Furthermore, we did not account for
PVs with early branching.
5 | CONCLUSION
No specific characteristics of PV dimensions or morphology were
associated with AF recurrence after cryoballoon PVI in patients with
paroxysmal AF. Further research on individual parameters associated
with the success or failure of PVI is essential.
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